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Objective
Describe the common work of Donetsk State Phthisiological Service 
and non-governmental organizations that has been conducted since 
2014 in order to achieve the global goal for tuberculosis elimination.
Introduction
The global strategy for eliminating tuberculosis (TB) epidemic 
“End TB” has been implemented in the world since 2016. Its main 
goal is to reduce the 2015 TB incidence rate by 90% and 2015 TB 
mortality rate by 95% by 2035. In Ukraine, in 2016, the incidence rate 
of new cases of tuberculosis among the general population was 54.7 
per 100 thousand of population (2015 - 55.9), the rate of decrease 
was 2.1 ± 0.1%. In Donetsk Oblast (that is under control of Ukrainian 
authorities), the incidence rate increased by 2.4% and was 56.4 per 
100 thousand of population. The mortality rates were 19 ± 0.6% in 
the country and 29 ± 2.5% in Donetsk Oblast. However, according 
to the World Health Organization (WHO) estimates, we need to 
enhance the annual incidence rate reduction by 10% by 2025, and 
TB mortality rate should be reduced to 6.5% in order to achieve the 
strategy-targeted values.
In Ukraine, as well as globally, there is a crisis of multidrug-
resistant tuberculosis (MDR-TB). According to WHO estimates, 
Ukraine belongs to five European countries where 2/3 of MDR-TB 
cases were registered; the proportion of MDR-TB cases among newly 
diagnosed TB cases was 16%, and 48% of repeated cases. In Ukraine, 
this rate is equal to 24.3% and 58.2% in Donetsk Oblast, respectively.
Such results in the Donetsk region may be related to the beginning 
of hostilities in eastern Ukraine in 2014, which lead to the active 
migration of population and breakdown of the supply of anti-TB 
drugs. According to monitoring data, 20% of with MDR-TB on the 
territory of the Donetsk region controlled by Ukraine were lost and 
did not seek medical assistance.
Methods
This work describes a retrospective cohort study of MDR-TB 
patients’ treatment efficacy. The MDR-TB diagnosis was confirmed 
by the BSL3 laboratory by molecular genetic testing of sputum using 
Gene Expert and bacteriological methods to determine resistance to 
rifampicin and isoniazid.
All MDR-TB patients were divided into 3 cohorts. The first 
cohort of 86 patients received outpatient treatment within the 
project “Outpatient Home Treatment Model Using Mobile Response 
Team” supported by the Foundation for Development of Ukraine 
in Kramatorsk, Donetsk Oblast, during one year (2014-2015). 
The response team consisting of a nurse, a driver and a doctor (if 
necessary) delivered drugs to patients with TB six times a week. 
The second cohort of 477 MDR-TB patients has received outpatient 
treatment via the Red Cross Society since 2015. A nurse visited 
patients every day and controlled drugs administration. In addition 
to the treatment, patients were given food kits twice a month. The 
third cohort of 391 MDR-TB patients received outpatient treatment 
in healthcare institutions without any support of non-governmental 
organizations. Before the beginning of the controlled treatment, 
psychologists worked with patients from risk groups.
Results
Surveillance data in Donetsk Oblast showed the increase of the 
MDR-TB morbidity rate from 15.0 to 20.1 per 100 thousand of 
population. According to the analysis results, MDR-TB is found in 
31% of cases among all newly diagnosed TB cases.
The successful treatment rate of all TB cases in Donetsk Oblast 
in 2015 was 61.9 ± 5.4%, which is lower than the average rate in 
Ukraine, which is 11.1 ± 1.0% (WHO indicator is 75%). The number 
of MDR-TB cases with “treatment failure” (treatment was completed, 
but bacterial secretion continued) - 9.3 ± 2.6% and “interrupted 
treatment” - 13.3 ± 2, 6% is very high in Donetsk Oblast.
Results analysis of the controlled treatment showed that the 
treatment efficacy for MDR-TB patients in the first cohort was 
75%. In the second cohort, 205 out of 477 patients completed their 
treatment. The treatment efficacy was 78.5%. In the third cohort 
45.0% of patients were cured, which corresponds to general rates in 
this oblast. However, the treatment efficacy for MDR-TB patients, 
who received the support of non-governmental organizations, was 
30,0-33.5% higher than among patients who did not receive such 
support (Table 1).
Conclusions
The cooperation of the State Phthisiatrician Service with non-
governmental organizations concerning patients at the outpatient 
stage of treatment and development of treatment adherence increased 
the treatment efficacy for MDR-TB patients by almost 30%, which is 
important to control the spread of dangerous sources of tuberculosis 
agents in order to improve the epidemic situation.
Cohort analysis of treatment results and clinical MDR-TB 
monitoring reflects the peculiarities of the epidemic situation and 
reveals errors in the work of the State Phthisiatrician Service in 
Donetsk Oblast. Nevertheless, the results show that common work 
of healthcare institutions, non-governmental organizations and 
volunteers can bring significant results in strengthening TB patients 
care.
Table 1. Treatment results of MDR-TB patients (2014-2016)
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